Spray-applied cell therapy with human allogenic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicenter, double-blind, randomised, placebo-controlled trial.

被引：0
|
作者：
Chleir, F.
机构：
来源：
PHLEBOLOGIE-ANNALES VASCULAIRES | 2012年 / 65卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
    Kirsner, Robert S.
    Marston, William A.
    Snyder, Robert J.
    Lee, Tommy D.
    Cargill, D. Innes
    Slade, Herbert B.
    LANCET, 2012, 380 (9846): : 977 - 985
  • [2] Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers
    Dale, JJ
    Ruckley, CV
    Harper, DR
    Gibson, B
    Nelson, EA
    Prescott, RJ
    BRITISH MEDICAL JOURNAL, 1999, 319 (7214): : 875 - 878
  • [3] The effectiveness of hyperbaric oxygen therapy for healing chronic venous leg ulcers: A randomized, double-blind, placebo-controlled trial
    Thistlethwaite, Kenneth R.
    Finlayson, Kathleen J.
    Cooper, P. David
    Brown, Bebe
    Bennett, Michael H.
    Kay, Graeme
    O'Reilly, Maria T.
    Edwards, Helen E.
    WOUND REPAIR AND REGENERATION, 2018, 26 (04) : 324 - 331
  • [4] A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers
    Arosio, E
    Ferrari, G
    Santoro, L
    Gianese, F
    Coccheri, S
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2001, 22 (04) : 365 - 372
  • [5] Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomised, double-blind, placebo-controlled pilot trial
    Cox, Charlotte
    Fry, Kirsty
    Sivakumaran, Yogeesan
    Spelman, Lynda
    Khosrotehrani, Kiarash
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 69 - 69
  • [6] Durability of healing from spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: A 6-month follow-up
    Kirsner, Robert S.
    Marston, William A.
    Snyder, Robert J.
    Lee, Tommy D.
    Cargill, D. Innes
    Zhang, Yuxin
    Dickerson, Jaime E., Jr.
    Slade, Herbert B.
    WOUND REPAIR AND REGENERATION, 2013, 21 (05) : 682 - 687
  • [7] Treatment of chronic diabetic lower leg ulcers with activated protein C: a randomised placebo-controlled, double-blind pilot clinical trial
    Whitmont, Kaley
    McKelvey, Kelly J.
    Fulcher, Gregory
    Reid, Ian
    March, Lyn
    Xue, Meilang
    Cooper, Alan
    Jackson, Christopher J.
    INTERNATIONAL WOUND JOURNAL, 2015, 12 (04) : 422 - 427
  • [8] Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial
    Park, Kwang Hwan
    Han, Seung Hwan
    Hong, Joon Pio
    Han, Seung-Kyu
    Lee, Doo-Hyung
    Kim, Bom Soo
    Ahn, Jae Hoon
    Lee, Jin Woo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 142 : 335 - 344
  • [9] The use of low energy photon therapy (LEPT) in venous leg ulcers: A double-blind, placebo-controlled study
    Gupta, AK
    Filonenko, N
    Salansky, N
    Sauder, DN
    DERMATOLOGIC SURGERY, 1998, 24 (12) : 1383 - 1386
  • [10] Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
    Tepper, Stewart
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan L.
    Dolezil, David
    Silberstein, Stephen
    Winner, Paul
    Leonardi, Dean
    Mikol, Daniel
    Lenz, Robert
    LANCET NEUROLOGY, 2017, 16 (06): : 425 - 434
12345